Compare Expeditors International of Wshngtn Inc (EXPD) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expeditors International of Wshngtn Inc vs Organon & Co. Common Stock — how do they compare? Expeditors International of Wshngtn Inc trades at $197.41 (market cap $25.37B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Expeditors International of Wshngtn Inc is far larger — about 7× Organon & Co. Common Stock's market cap, and Expeditors International of Wshngtn Inc pays the higher dividend (0.83%). Which is the better fit depends on your goals — on Pluang, investors hold Expeditors International of Wshngtn Inc for 44 Days and Organon & Co. Common Stock for 0 Days on average.
| EXPD | OGN | |
|---|---|---|
Market Cap | $25.37B | $3.62B |
Volume | 1,236,812 | 2,892,999 |
Sector | Industrials | Health |
52-Week High | $196.38 | $13.81 |
52-Week Low | $117.35 | $5.70 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $24.90B | $11.04B |
Dividend Yield | 0.83% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXPD trades at $195.13, up 0.89% today, with strong technical momentum showing bullish moving averages and trading near resistance at $196. The company demonstrates robust fundamentals with three consecutive quarterly earnings beats, ROE of 42.6%, and revenue growth from $10.6B to $11.1B in 2025. Recent news highlights efficiency initiatives and AI-driven freight market opportunities.
Outlook remains positive with earnings momentum and operational efficiency gains, though valuation appears stretched at 28.4 P/E. Key risks include freight market volatility and competitive pressures. Analyst consensus is cautious with 63.6% hold ratings and $179.43 target below current price, suggesting limited near-term upside despite strong fundamentals.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Expeditors International of Wshngtn Inc
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
